Elucidation of the pathway for biosynthesis of saponin adjuvants from the soapbark tree

Abstract

The Chilean soapbark tree (<i>Quillaja saponaria</i>) produces soap-like molecules called QS saponins that are important vaccine adjuvants. These highly valuable compounds are sourced by extraction from the bark, and their biosynthetic pathway is unknown. Here, we sequenced the <i>Q. saponaria</i> genome. Through genome mining and combinatorial expression in tobacco, we identified 16 pathway enzymes that together enable the production of advanced QS pathway intermediates that represent a bridgehead for adjuvant bioengineering. We further identified the enzymes needed to make QS-7, a saponin with excellent therapeutic properties and low toxicity that is present in low abundance in <i>Q. saponaria</i> bark extract. Our results enable the production of <i>Q. saponaria</i> vaccine adjuvants in tobacco and open the way for new routes to access and engineer natural and new-to-nature immunostimulants.